RESX Financials 07/16/2014 02:12:36
RestorGenex Corporation
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 72 375 570 40
Cost of Revenue - 236 2,309 210
Gross Profit 72 139 (1,738) (170)
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 9,306 8,214 9,456 5,102
Non-Recurring Items 3,007 3,553 5,166 2,315
Other 676 164 70 50
Operating Income (12,917) (11,792) (16,429) (7,637)
Income From Continuing Operations
Add'l Income/Expense Items 10,688 5,110 (6,176) (691)
Earnings Before Interest and Tax (2,230) (6,682) (22,605) (8,328)
Interest Expense 228 168 31 81
Earnings Before Tax (2,458) (6,850) (22,636) (8,410)
Income Tax - - - -
Minority Interest 6 19 - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,464) (6,869) (22,636) (8,410)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,464) (6,869) (22,636) (8,410)
Preferred Stock and Other Adjustments (172) (497) (390) -
Net Income Applicable to Common Shareholders (2,636) (7,366) (23,026) (8,410)